Windy City Media Group Frontpage News Home
CELEBRATING 28+ YEARS OF Lesbian Gay Bisexual and Transgender NEWS

Search Gay News Articles
Advanced Search
Gay News Sponsor Windy City Times 2014-07-23
Download Issue
  News Index       Archives   About WCMG    Publications    Bars & Clubs     Calendar   Videos   Advertisers    OUT! Guide    Classifieds   AIDS @ 32
 Local | National | World | Politics | Obits | Profiles | Views | Entertainment | Theater | Dance | Music | Film | Art | Books | TV/Gossip
 Travel | History | Marriage | Youth | Trans | Lesbian | Celebrations | Food | Nightlife | Sports | Health | Real Estate | Autos | Pets | Crime

Chicago native takes over as president of CMSA Chicago native takes over as president of CMSA
Michael Erwin, a Chicago native who has participated in gay sports since ...

Browse Gay News Index   Browse Gay News Archives
  Windy City Times

Forum explores Truvada's use in fighting HIV
by Kate Sosin, Windy City Times
2011-06-22

facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email
From left: Rico, Keith Green and Dr. Robert Grant at the talk. Photo by Kate Sosin


When Gladstone Institutes released evidence that Truvada, a one-a-day HIV pill, might prevent HIV in addition to treating it, the news sparked both excitement and skepticism.

The AIDS Healthcare Foundation (AHF), the largest HIV/AIDS medical provider in the country, came out against the use of Truvada for prevention, despite the fact that Gladstone's Iniciativa Profilaxis Preexposicion (iPrEx) trial showed the drugs to be more than 90-percent effective in preventing HIV in those who took it daily.

Experts on the study sat down with Feast of Fun podcasters Fausto FernĂ"s and Marc Felion at Center on Halsted June 15 to talk about what the study means and if Truvada could signal the end of the pandemic. Present were Dr. Robert Grant of Gladstone Institute, Keith Green, director of federal affairs at AIDS Foundation of Chicago, and a youth who participated in a similar study Green conducted in Chicago.

"In our wildest dreams, we did not think [Truvada] would be more than 90-percent effective in those who took it," Grant told the audience.

The findings also astounded Green, who halted Project PrEPare, a similar Chicago study, because he didn't want to continue administering placebos when he knew Truvada worked.

While the effectiveness of Truvada in preventing HIV is clear, the practicality of it remains uncertain. For one, Truvada is meant to be taken daily, which could pose a challenge to many not accustomed to the routine or whose lives don't always allow for consistency, such as youth living on the street. Additionally, Truvada is not without side effects including nausea, although that tends to go away over prolonged use, said Grant.

One barrier in getting people to use Truvada is stigma, Grant said.

"These pills, in particular, have been the one thing that folks want to avoid," he said, adding that fear surrounding HIV/AIDS contributes to fear around taking Truvada for prevention. "It strikes people as a misuse [of the drug]."

The drug could cost as much at $10,000 a year, an impossibly high price for people without insurance. In Illinois, the AIDS Drug Assistance Program (ADAP) which provides antiretrovirals to those who cannot afford them, is already cash-strapped. Truvada used for prevention could compete with Truvada treatments, creating a kind of Catch-22 for service providers who want to end the spread of HIV but also serve those who are positive already.

"We really have an ethical dilemma," Green said.

Still, many insurance companies are interested in Truvada for prevention because even with the cost of the drug, prevention is at least half the cost of treatment.

Rico, the youth who participated in Green's Chicago study on Truvada said that taking the drug made him "more considerate" of his body and protecting himself. He said that he had been hesitant to participate in the study but decided to sign up when he learned of the impact it could have on his community.

Grant and Green did acknowledge that iPrEx study had its shortcomings.

"I started to look at Dr. Grant's work, and those people didn't look like our people," Green said, adding that a low number of youth and African Americans had participated. Grant agreed and noted that their efforts would seek the expertise of Chicago service providers whose work included a diversity of clients. Still he added, the drug seemed to work equally well among people of every race.

As for AHF's critiques of using Truvada for prevention, neither Grant nor Green seemed to give them much weight.

"This is a large corporation, actually that has revenues above 300 million dollars a year, so well above my pay grade," said Grant, who went on to say that he was not certain about why AHF was working to discredit the trial results.

Truvada is awaiting FDA approval before it can be marketed for HIV prevention. Grant said that Gilead, the company that makes Truvada, will likely be hesitant to market the drug for prevention and that it will be up to AIDS service providers to make the leap in making Truvada more accessible.

For some, that leap can't come quickly enough.

"We either pay now or we pay forever," Grant said. "We have a chance now to stop this epidemic."


facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.

Report: PrEP 90% effective with just a few doses per week 2014-07-23
Journalist Vargas detained; Lambda Legal's call 2014-07-22
Clinical counselor Matthew Dempsey on gay men, body image 2014-07-22
LGBT youth more likely than heterosexual youth to try suicide 2014-07-22
Six of airliner fatalities confirmed as AIDS researchers/activists 2014-07-21
Hundreds gather for Chicago Disability Pride 2014-07-20
Obama praises work of AIDS researchers killed in plane crash 2014-07-18
AIDS researchers, activists reportedly among crash fatalities 2014-07-17
CDC educates on dangers of smoking for HIV+ 2014-07-16
Conflict Center to mediate for Ryan White grievances 2014-07-16
HIV cure: One step back, many paths forward 2014-07-16
Black LGBT trailblazers; Maddow talks Perry; ENDA debate 2014-07-16
ASK LAMBDA LEGAL Sex-reassignment surgery and Medicare 2014-07-15
Program to look at fertility options for lesbians 2014-07-15
Progress in four years of the National HIV/AIDS strategy 2014-07-15
An Evening of Magic July 26 to support AFC 2014-07-14
Howard Brown takes part in gay blood drive 2014-07-14
History made, honored in annual Ride For AIDS Chicago 2014-07-13
Child with HIV, once thought cured, shows re-infection signs 2014-07-11
Howard Brown to host gay blood drive July 11 2014-07-10
Tim Emond returns for Ride for AIDS 2014-07-08
Love grows as lesbians fight HIV/AIDS, stigma 2014-07-08
Study: Children of same-sex parents are healthier 2014-07-07
City resolution salutes 11th annual Ride for AIDS Chicago 2014-07-07
Collins, Red Ribbon sponsor, observes Nat'l HIV Test Day 2014-07-04
Study: Religious counseling associated with suicide tries 2014-07-03
Annual Ride For AIDS Chicago is July 12-13 2014-07-03
Bisexual Research Collaborative On Health formed 2014-07-02
HBHC's HEALE program: Educating nurses about LGBTQ elders 2014-07-02
Supreme Court lets stand CA's ban on ex-gay therapy 2014-07-01
2014 AIDS Run & Walk Chicago to raise funds for 31 groups 2014-06-30
Surgeon General video warns on high LGBT smoking rates 2014-06-27
HBHC town hall tackles youth health issues 2014-06-22
AMA adopts new policy on gender-change requirements 2014-06-19
Jenifer Lewis talks versatility, HIV/AIDS, bipolar disorder 2014-06-18
AFC, CDPH urge HIV advocates to 'Ready, Set, PrEP' 2014-06-17
Two Lake View events focus on LBTQ health 2014-06-17
Medicare lifts ban on trans surgical procedures 2014-06-17
Ride for AIDS Chicago July 13 2014-06-15
Federal employee health plans to include transition-related care 2014-06-14





Copyright © 2014 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
the online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 



 

Report: PrEP 90% effective with just a few doses per week
 
John D'Emilio: Renowned professor, historian retires
 
'An Evening of Magic' to benefit AFC
 
NLGJA names LGBT Journalist Hall of Famers, Excellence honorees
 
Meiling Jin on growing up in China, celebrity, LGBT journalism
 
Windy City Times Current DownloadNightspots Current DownloadQueercast Current Download
Windy City Media Group BlogsJoin Our Email List!Donate Now








  News Index       Archives   About WCMG    Publications    Bars & Clubs     Calendar   Videos   Advertisers    OUT! Guide    Classifieds   AIDS @ 32
 Local | National | World | Politics | Obits | Profiles | Views | Entertainment | Theater | Dance | Music | Film | Art | Books | TV/Gossip
 Travel | History | Marriage | Youth | Trans | Lesbian | Celebrations | Food | Nightlife | Sports | Health | Real Estate | Autos | Pets | Crime



About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video      News Videos      Nightspots Videos      Entertainment Videos      Queercast Videos      Comedy Videos     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.